Use of Magnetic Fields and Nanoparticles to Trigger Drug Release and Improve Tumor Targeting

Overview

Journal Wiley Interdiscip Rev Nanomed Nanobiotechnol

Specialty Biotechnology

Date 2019 Jun 27

PMID 31241251

Citations 51

Authors

Jessica F Liu

Bian Jang

David Issadore

Andrew Tsourkas

Affiliations

Soon will be listed here.

Abstract

Drug delivery strategies aim to maximize a drug's therapeutic index by increasing the concentration of drug at target sites while minimizing delivery to off-target tissues. Because biological tissues are minimally responsive to magnetic fields, there has been a great deal of interest in using magnetic nanoparticles in combination with applied magnetic fields to selectively control the accumulation and release of drug in target tissues while minimizing the impact on surrounding tissue. In particular, spatially variant magnetic fields have been used to encourage accumulation of drug-loaded magnetic nanoparticles at target sites, while time-variant magnetic fields have been used to induce drug release from thermally sensitive nanocarriers. In this review, we discuss nanoparticle formulations and approaches that have been developed for magnetic targeting and/or magnetically induced drug release, as well as ongoing challenges in using magnetism for therapeutic applications. This article is categorized under: Diagnostic Tools > in vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.

Citing Articles

Magnetic-Plasmonic Core-Shell Nanoparticles: Properties, Synthesis and Applications for Cancer Detection and Treatment.

Rodriguez-Nieves A, Shah S, Taylor M, Alle M, Huang X Nanomaterials (Basel). 2025; 15(4).

PMID: 39997827 PMC: 11858323. DOI: 10.3390/nano15040264.

Advances in engineering nanoparticles for magnetic particle imaging (MPI).

Velazquez-Albino A, Imhoff E, Rinaldi-Ramos C Sci Adv. 2025; 11(2):eado7356.

PMID: 39772674 PMC: 11708890. DOI: 10.1126/sciadv.ado7356.

Physical modulation and peripheral nerve regeneration: a literature review.

Zhai X, Wang Y Cell Regen. 2024; 13(1):32.

PMID: 39710804 PMC: 11663830. DOI: 10.1186/s13619-024-00215-9.

Magnetic and pH sensitive nanocomposite microspheres for controlled temozolomide delivery in glioblastoma cells.

Ahmadi M, Ashoub M, Heydarian K, Heydaryan K, Abolghasemi S, Dawi E Sci Rep. 2024; 14(1):29897.

PMID: 39622938 PMC: 11612508. DOI: 10.1038/s41598-024-80596-8.

Targeted Magnetic Nanoparticles for Beta-Amyloid Detection.

Chmelyuk N, Nikitin A, Vadekhina V, Mitkevich V, Abakumov M Pharmaceutics. 2024; 16(11).

PMID: 39598519 PMC: 11597426. DOI: 10.3390/pharmaceutics16111395.

References

Feng Q, Liu Y, Huang J, Chen K, Huang J, Xiao K . Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci Rep. 2018; 8(1):2082. PMC: 5794763. DOI: 10.1038/s41598-018-19628-z. View

Chen B, Dai W, He B, Zhang H, Wang X, Wang Y . Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. Theranostics. 2017; 7(3):538-558. PMC: 5327631. DOI: 10.7150/thno.16684. View

Li T, Huang C, Ruan P, Chuang K, Huang K, Shieh D . In vivo anti-cancer efficacy of magnetite nanocrystal--based system using locoregional hyperthermia combined with 5-fluorouracil chemotherapy. Biomaterials. 2013; 34(32):7873-83. DOI: 10.1016/j.biomaterials.2013.07.012. View

Ortiz de Solorzano I, Alejo T, Abad M, Bueno-Alejo C, Mendoza G, Andreu V . Cleavable and thermo-responsive hybrid nanoparticles for on-demand drug delivery. J Colloid Interface Sci. 2018; 533:171-181. DOI: 10.1016/j.jcis.2018.08.069. View

Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

Lubbe A, Alexiou C, Bergemann C . Clinical applications of magnetic drug targeting. J Surg Res. 2001; 95(2):200-6. DOI: 10.1006/jsre.2000.6030. View

Naqvi S, Samim M, Abdin M, Jalees Ahmed F, Maitra A, Prashant C . Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine. 2010; 5:983-9. PMC: 3010160. DOI: 10.2147/IJN.S13244. View

Guo Y, Zhang Y, Ma J, Li Q, Li Y, Zhou X . Light/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics. J Control Release. 2017; 272:145-158. DOI: 10.1016/j.jconrel.2017.04.028. View

Boissenot T, Bordat A, Fattal E, Tsapis N . Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications. J Control Release. 2016; 241:144-163. DOI: 10.1016/j.jconrel.2016.09.026. View

10.

Hajiaghajani A, Abdolali A . Magnetic field pattern synthesis and its application in targeted drug delivery: Design and implementation. Bioelectromagnetics. 2018; 39(4):325-338. DOI: 10.1002/bem.22107. View

11.

Pernia Leal M, Torti A, Riedinger A, La Fleur R, Petti D, Cingolani R . Controlled release of doxorubicin loaded within magnetic thermo-responsive nanocarriers under magnetic and thermal actuation in a microfluidic channel. ACS Nano. 2012; 6(12):10535-45. DOI: 10.1021/nn3028425. View

12.

Bobo D, Robinson K, Islam J, Thurecht K, Corrie S . Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. Pharm Res. 2016; 33(10):2373-87. DOI: 10.1007/s11095-016-1958-5. View

13.

Banchelli M, Nappini S, Montis C, Bonini M, Canton P, Berti D . Magnetic nanoparticle clusters as actuators of ssDNA release. Phys Chem Chem Phys. 2014; 16(21):10023-31. DOI: 10.1039/c3cp55470h. View

14.

Yang R, An L, Miao Q, Li F, Han Y, Wang H . Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes. Oncotarget. 2016; 7(24):35894-35916. PMC: 5094971. DOI: 10.18632/oncotarget.9116. View

15.

Daldrup-Link H, Golovko D, Ruffell B, DeNardo D, Castaneda R, Ansari C . MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res. 2011; 17(17):5695-704. PMC: 3166957. DOI: 10.1158/1078-0432.CCR-10-3420. View

16.

Sun S, Zeng H, Robinson D, Raoux S, Rice P, Wang S . Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004; 126(1):273-9. DOI: 10.1021/ja0380852. View

17.

Mahmoudi M, Sant S, Wang B, Laurent S, Sen T . Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2010; 63(1-2):24-46. DOI: 10.1016/j.addr.2010.05.006. View

18.

Hormann K, Zimmer A . Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review. J Control Release. 2015; 223:85-98. DOI: 10.1016/j.jconrel.2015.12.016. View

19.

Bae Y, Park K . Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011; 153(3):198-205. PMC: 3272876. DOI: 10.1016/j.jconrel.2011.06.001. View

20.

Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X . Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. ACS Nano. 2016; 10(3):3323-33. DOI: 10.1021/acsnano.5b06939. View